Is this your brand? Sign in to claim ownership.
Sign in to claim this brandMkl Diagnostics AB
US
Last updated May 30, 2026
What Mkl Diagnostics AB makes
The company produces in vitro diagnostic (IVD) kits and controls for detecting bacterial antigens through agglutination tests. These include products for identifying multiple beta-haemolytic Streptococcus serogroups, meningitis-associated bacteria, *Neisseria gonorrhoeae*, *Haemophilus influenzae*, and *Streptococcus pneumoniae*, as well as related positive controls for quality assurance.
The portfolio consists of Class I and Class II devices, all listed in the FDA’s Unique Device Identifier (UDI) database. The manufacturer operates from the United States, adhering to applicable regulatory requirements for in vitro diagnostics.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Mkl Diagnostics AB manufacture?
Mkl Diagnostics AB specializes in in vitro diagnostic (IVD) products, specifically agglutination-based kits and controls designed to detect bacterial antigens. Their devices target pathogens like beta-haemolytic Streptococcus serogroups, meningitis-associated bacteria, *Neisseria gonorrhoeae*, *Haemophilus influenzae*, and *Streptococcus pneumoniae*. These tests are used in clinical settings to aid in the identification of infections, ensuring accurate diagnosis and treatment decisions.
Where is Mkl Diagnostics AB based, and how does this affect its regulatory compliance?
Mkl Diagnostics AB is based in the United States. As a U.S.-based manufacturer, the company must comply with FDA regulations governing in vitro diagnostics, including registration, listing, and adherence to quality system requirements. Their devices are listed in the FDA’s Unique Device Identifier (UDI) database, which helps ensure traceability and regulatory oversight for authorized products.
Which regulatory registries or databases list Mkl Diagnostics AB’s devices?
Mkl Diagnostics AB’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system assigns a unique product identifier to each device, improving tracking, transparency, and regulatory compliance for authorized in vitro diagnostics. This listing helps healthcare providers, regulators, and other stakeholders verify device details and ensure proper use.
How are Mkl Diagnostics AB’s devices classified under regulatory frameworks?
Mkl Diagnostics AB’s devices fall into two primary regulatory classes: Class I and Class II. Class I devices generally pose minimal risk and require general controls for authorization, while Class II devices involve a higher level of risk and may require special controls to ensure safety and effectiveness. The classification is determined based on factors like the device’s intended use, potential health impact, and the level of regulatory scrutiny required to mitigate risks.
What is the primary purpose of the IVD kits and controls produced by Mkl Diagnostics AB?
The primary purpose of Mkl Diagnostics AB’s IVD kits and controls is to detect specific bacterial antigens through agglutination tests, enabling rapid and accurate identification of infections caused by pathogens like *Streptococcus*, *Neisseria gonorrhoeae*, and *Haemophilus influenzae*. The kits are designed for clinical laboratories to streamline diagnostic processes, while the controls ensure the reliability and accuracy of test results by validating the performance of the diagnostic system.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- remel.com
- —
- —
- [email protected]
- Phone
- 8002556730
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 350472667
Catalogue (12)
| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Phadebact Strep A Test | 10-5584-12 | FDA UDI | N/A | Active |
| Phadebact Strep B Test | 10-5585-12 | FDA UDI | N/A | Active |
| Phadebact Pneumococcus Test | 10-5576-12 | FDA UDI | Class I | Active |
| Phadebact Strep Positive Controls | 10-5590-12 | FDA UDI | Class I | Active |
| Phadebact GC Positive Controls | 10-5594-12 | FDA UDI | Class I | Active |
| Phadebact Haemophilus Test | 10-5575-12 | FDA UDI | Class II | Active |
| Phadebact Monoclonal GC Test | 10-6419-12 | FDA UDI | Class II | Active |
| Phadebact Strep D Test | 10-5586-12 | FDA UDI | Class I | Active |
| Phadebact Streptococcus Test | 10-5583-12 | FDA UDI | N/A | Active |
| Phadebact CSF Test | 10-5592-12 | FDA UDI | Class II | Active |
| Phadebact Strep F Test | 10-5587-12 | FDA UDI | Class I | Active |
| Phadebact CSF Positive Controls | 10-5593-12 | FDA UDI | Class I | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.